Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
viviana.frantellizzi@uniroma1.it
Viviana Frantellizzi
Ricercatore
Struttura:
DIPARTIMENTO DI SCIENZE RADIOLOGICHE, ONCOLOGICHE E ANATOMO-PATOLOGICHE
E-mail:
viviana.frantellizzi@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
The rare case of positive FDG-positron emission tomography for giant cavernous hemangioma of the liver
BRITISH JOURNAL OF RESEARCH
2017
Ra-223 dichloride management in a nuclear medicine unit: experience of a referral institution
JOURNAL OF RADIOLOGY AND ONCOLOGY
2017
Midbrain Serotonin transporter (SERT) evaluation by 123I-FP-CIT: a one-year retrospective study
Eur J Nucl Med Mol ImagingEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2017
Rest/Stress vs. Stress only Myocardial Perfusion Imaging. How many exams could be avoided? Our experience
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2017
Rare paranganglioma localizations caught by MRI and CT hybrid 123I-MIBG SPECT imaging.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2017
223Radium: analysis of effect of treatment in bone oligo-metastatic CRPC patients
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2017
Role of tALP and ECOG Performance Status in predicting survival in mCRPC patients receiving 223Ra-dichloride
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2017
Definition of a Predictive Score to guide therapeutic management in metastatic CRPC patients eligible to Radium-223
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2017
Analysis of Clinical parameters for the outcame prediction of mCRPC patients treated with Ra-223-dichloride
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2017
Radium-223 in metastatic castration-resistant prostate cancer (mCRPC):efficacy and safety in real-life experience
ANNALS OF ONCOLOGYANNALS OF ONCOLOGY
2017
Dose-response correlation in radioiodine therapy of hyperthyroidism from nodular thyroid disease
Eur J Nucl Med Mol Imaging
2017
Mixed leukocytes separation for scintigraphic purposes: assessment of red blood cells contamination
Clinical and Translational ImagingCLINICAL AND TRANSLATIONAL IMAGING
2017
Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2016
Us Integrated Probe with a Micro Gamma Camera for Dual Modality Imaging in Medi- cal Diagnostics.
PROCEEDINGS BOOK
2016
Prostate-specific antigen flare phenomenon during 223Ra-Dichloride treatment for bone metastatic castration-resistant prostate cancer: a case report
CLINICAL GENITOURINARY CANCER
2016
Use of 123I-MIBG SPECT in association with 123I-FP-CIT in patients with Early Parkinson’s Disease: a new point of view.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2016
Correlation between Bone Lesion Dosimetry and Pain Outcome in Patients (pts) with Castration-Resistant Prostate Cancer (CRPC)undergoing 223Ra-dichloride Therapy
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2016
Psychological status and pain outcome evaluation in patients with painful bone metastases from castration resistant prostate cancer treated with 223Radium.
JOURNAL OF CLINICAL ONCOLOGYJOURNAL OF CLINICAL ONCOLOGY
2016
Role of psychological status related to pain outcome and bone lesion dosimetry in patients with bone metastatic Castration-Resistant Prostate Cancer (mCRPC) treated with 223Radium
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2016
Lesion dosimetry for Ra-223 therapy of bone metastases from castration-resistant prostate cancer: patients eligibility criterion and update of dosimetric assessments
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2016
« prima
< precedente
1
2
3
4
5
6
7
8
9
10
seguente ›
ultima »
ERC
LS7_1
KET
Life-science technologies & biotechnologies
Keywords
nuclear medicine and imaging
molecular imaging
iodine radioisotopes
Gruppi di ricerca
Gruppo di ricerca sull'amiloidosi sistemica da transtiretina
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma